Skip to main content

COVID-19 Outbreak: How Respiratory Disease Testing Market Will Shape Having Biggies with Strong Fundamentals?

  The coronavirus pandemic has made a significant impact on the global respiratory disease testing market. Moreover, clinical laboratories will have lucrative market growth, throughout the forecast period. Clinical laboratories are expected to achieve newer heights. The key players of the respiratory disease testing market are following effective strategies to acquire a prominent position in the global industry.

The communal transmission of coronavirus has created a significant impact on the global respiratory disease testing market. The growth of the global market is mainly driven by the extensively rising number of respiratory disease patients with COPD (chronic obstructive pulmonary disease) and asthma. In addition, technological developments in the diagnosis and treatment of respiratory diseases are also anticipated to augment the growth of the global respiratory disease testing market. Though the industries across the countries such as China, India, and Brazil are massively disrupted due to the COVID-19 outbreak, the demand for respiratory disease testing has shown exponential growth, in the pandemic timeframe. Therefore, to mitigate the communal spread of COVID-19 pandemic, major players of the market such as Abbtt., Thermo Fisher Scientific Inc., and ResMed are coming forward with new strategy implementation. In March 2020, Thermo Fisher Scientific has made an announcement of the collaboration with Janssen Biotech (Johnson & Johnson) to develop a companion diagnostic for lung cancer. These elements may boost the growth of respiratory disease testing in the global market, in the upcoming years.

[ What will the sample contain?
The sample will give the stakeholder an outline of the report. It will give an overview/framework of the aspects of the market that have been covered in the content of the actual report. The report, unlike the sample, will bear numerical data and market insights associated with a price. ]

As per the recent publication of Research Dive, the global respiratory disease testing market is set to generate a revenue of $20.1 billion by 2027, at a noteworthy growth rate of 9.2%, throughout the projected period. The segmentation of the global respiratory disease testing market has been done based on the end-use, product, and region. The report provides key insights on driving factors vital segments, opportunities, restraints, and industry leaders of the global respiratory disease testing market.

The Factors Affecting Market Growth

As per our analyst estimates, the significantly growing prevalence of chronic respiratory disorders such as asthma, cystic fibrosis, and sleep apnea is accelerating the growth of the global respiratory disease testing market. However, the rising healthcare costs are anticipated to hamper the growth of the global respiratory disease testing market, during the forecast period.

Imaging Test Products Shall Have Significant Market Growth

Depending on the product, the global market for respiratory disease testing is classified into respiratory measurements, imaging tests, blood gas tests, and others. The imaging test products are valued at $12.4 billion in 2027 and are anticipated to rise at 9.6% growth rate; due to the growing adoption of x-ray imaging and other imaging devices for improved visualization of the disease condition.

Clinical Laboratories to Be The Most Lucrative

On the basis of end-use, the global market is mainly fragmented into physicians’ clinics, hospitals, clinical laboratories, and others. The Clinical laboratories shall have lucrative opportunities and are projected to register a revenue of $4.6 billion at a significant CAGR of 9.8%, during the analysis period. However, the hospital shall have a substantial market share and is expected to surpass $11.1 billion in 2027, at a 9.3% growth rate.

Geographical Analysis and Leading Market Players

Depending on the geographical region, the global market respiratory disease testing is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia-Pacific respiratory disease testing market valued $5.3 billion in 2027 and is anticipated to grow at 10.0% lucrative CAGR throughout the analysis period; owing to the extensively growing patient of respiratory diseases and increasing spending in R&D particularly in China, South Korea, and India.

The leading companies of the respiratory disease testing market consist BD., Koninklijke Philips N.V., COSMED srl, bioMérieux SA, SDI Diagnostics, CARESTREAM MEDICAL., Abbott., ResMed, Thermo Fisher Scientific Inc., and Seegene Inc.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Comments

Post a Comment

Popular posts from this blog

Growth Outlook: Healthcare Gamification Market Expand their Businesses with New Investments

   Download FREE Sample The healthcare gamification market share is predicted to grow at a CAGR of 11.9% by generating a revenue of $47,281.5 Million by 2026. Gamification includes applying the techniques used in game, mechanics of game, and game style in non-gaming applications to engage the audience and make the dull task into more fun and engaging. Basically it is an application of elements in video games, which helps to solve the everyday problem and enables the user to change the behavior, develop skills and enable innovation in health care. The  goal of the gamification  is to change the behavior of the patient. The increase in the wearables and health & wellness app with gamification is the strong sign that the people are liking it. The increase in the usage of digitalization and the technology adoption are expected to drive the healthcare gamification market. Many companies are using the digital platform for the people to check their health data. For...
Post a Comment
Read more

COVID-19 Impact: What Challenges Hand Sanitizer Market May See In Next 5 Years?

   Inquire Here Before Purchase and Get FREE Sample The communal transmission of COVID-19 has created a significant impact on the hand sanitizer market growth, throughout the projected timeframe. The growth of the global hand sanitizer market is mainly driven by the rising concern about personal safety among the customers. Furthermore, the extensively growing prevalence of viral disorders globally is also creating a huge demand for hand sanitizers, in the review period. Though the businesses across the globe have strictly imposed lockdown in order to reduce the impact of the pandemic spread, the  global hand sanitizer industry  has shown exponential growth. The ventures involved with hand sanitizer production are adopting numerous strategic steps like product & technology advancements, strategic tie-ups. For example, in June 2020, Procter & Gamble (P&G), has made an announcement to launch of newly invented ‘safeguard sanitizer’. In addition, the enterpris...
Post a Comment
Read more

What are the Left Atrial Appendage Closure Devices Market Key Insights and COVID-19 Business Impact?

   Download FREE Sample Connect with Analyst The COVID-19 outbreak has significantly affected the global left atrial appendage closure devices market. As per American Heart Association, people having high blood pressure, heart valve disease and congenital heart diseases are expected to develop severe coronavirus symptoms. Also, this virus can generate heart strokes through weakening of muscles of the heart. These fators will boost the demand for left atrial appendage closure divices and surge the market growth during the pandemic. Furthermore, the leading manufactures in the global market are adopting various strategies such as product innovations and partnerships to increase their market share in the overall industry. For example, in July 2020, Boston Scientific Corporation announced that the “Watchman FLX left atrial appendage closure device” has been approved by U.S. Food and Drug Administration, which is used to minimize the threat of heart stroke in patients. The stroke r...
Post a Comment
Read more